This webinar will highlight the critical role of metabolomics in oncology, aiming to engage a diverse audience in discussions about the latest advancements in metabolomic technologies and their application in cancer research. A key focus will be on metabolomics’ ability to identify novel biomarkers in neuroblastoma, aiding in early detection, disease monitoring, and treatment evaluation in a challenging cancer phenotype.
Metabolomics has emerged as a key technology in oncology research, offering a comprehensive view of the biochemical processes and the resulting impact on cancer progression and treatment. This field has evolved from merely cataloguing metabolites as part of cellular biochemistry to recognizing their significant roles as regulators of cancer-specific phenotypes, including malignant transformation, cell proliferation, and metastasis. The discovery of oncometabolites like 2-hydroxyglutarate in IDH1-mutated cancers underscores the importance of metabolites in directly influencing cancer pathways. Metabolomic profiling within the tumor microenvironment and circulation is now pivotal for understanding cancer mechanisms and identifying therapeutic targets.
This webinar will highlight the critical role of metabolomics in oncology, aiming to engage a diverse audience in discussions about the latest advancements in metabolomic technologies and their application in cancer research. A key focus will be on metabolomics’ ability to identify novel biomarkers in neuroblastoma, aiding in early detection, disease monitoring, and treatment evaluation in a challenging cancer phenotype.
Furthermore, we will explore the integration of metabolomics within the multiomics framework, emphasizing its indispensable role alongside genomics and transcriptomics. This integrative approach not only enriches our understanding of the molecular complexity of cancer but also supports the identification of molecular subtypes and informs personalized treatment strategies. As the final frontier in the multi-omics cascade, metabolomics reflects the ultimate phenotype and provides a direct link to the clinical picture, thereby enhancing precision medicine efforts in oncology.
You will learn:
Metabolites in Cancer Biology – Learn the history of oncometabolite identification, establishing cancer as a metabolic disease.
Biomarker Discovery in Neuroblastoma – Explore how metabolomics aids in early detection, disease monitoring, and treatment evaluation.
Multiomics Integration – Understand how metabolomics complements genomics and transcriptomics to further our functional understanding of cancer biology and refine cancer subtyping.
Precision Medicine & Clinical Impact – Discover how metabolomics links biochemical changes to clinical outcomes, enhancing precision oncology.
Offered Free by: Metabolon
See All Resources from: Metabolon
